NHE7 antibody
Quick Overview for NHE7 antibody (ABIN635882)
Target
See all NHE7 (SLC9A7) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Affinity purified
-
Immunogen
- SLC9 A7 antibody was raised using a synthetic peptide corresponding to a region with amino acids LGWGLRVAAAASASSSGAAAEDSSAMEELATEKEAEESHRQDSVSLLTFI
-
-
-
-
Application Notes
-
WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
SLC9A7 Blocking Peptide, (ABIN940387), is also available for use as a blocking control in assays to test for specificity of this SLC9A7 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SLC0 7 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NHE7 (SLC9A7) (Sodium Hydrogen Exchanger 7 (SLC9A7))
-
Alternative Name
- SLC9A7
-
Background
- Organelles of the secretory and endocytic pathways are distinguished by their luminal acidity, which is generated by the activity of an electrogenic vacuolar-type hydrogen ATPase. Progressive acidification of vesicles in the endocytic pathway is essential for the redistribution and degradation of internalized membrane proteins, such as ligand receptor complexes and fluid-phase solutes. It may play an important role in maintaining cation homeostasis and function of the trans-Golgi network.
-
Molecular Weight
- 80 kDa (MW of target protein)
Target
-